Table 3.
Compound |
lacZ |
MN |
|||||
---|---|---|---|---|---|---|---|
GS | SI | Lv | Lg | BM | RETs | NCEs | |
BaP | +++ | +++ | +++ | +++ | +++ | + | ++ |
BaA | + | + | WP | − | + | − | − |
DBahA | + | +++ | + | +++ | − | + | + |
BbF | +++ | +++ | +++ | ++ | ++ | + | + |
CHRY | − | + | − | WP | − | − | − |
BkF | + | ++ | + | + | + | + | + |
INDENO | + | +++ | + | + | + | − | − |
BghiP | − | + | − | + | − | − | − |
DBalP | ++ | + | ++ | + | +++ | ++ | + |
Total Pos | 7 | 9 | 7 | 8 | 6 | 5 | 5 |
Total Neg | 2 | 0 | 2 | 1 | 3 | 4 | 4 |
Sensitivity | 78% | 100% | 78% | 89% | 67% | 56% | 56% |
+: Dose–response, 1.5–5-fold above background; ++: Dose–response, 5–10-fold above background; +++: Dose–response, > 10-fold above background; WP (weak positive): dose–response, but below 1.5-fold above background; −: Negative.